Menu Search
Equities

Arcadia Biosciences Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
17D:MUN

Arcadia Biosciences Inc

Actions
  • Price (EUR)3.86
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-17.52%
  • Beta0.6042
Data delayed at least 15 minutes, as of Feb 24 2025 07:19 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.

  • Revenue in USD (TTM)5.17m
  • Net income in USD-5.04m
  • Incorporated2015
  • Employees9.00
  • Location
    Arcadia Biosciences Inc5956 Sherry Lane, Suite 2000DALLAS 75225United StatesUSA
  • Phone+1 (214) 974-8921
  • Fax+1 (530) 756-7027
  • Websitehttps://arcadiabio.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.